Esthetic and Radiographic Outcomes Following Immediate Implant Placement With Thin or Dehiscence Buccal Bone Wall

February 8, 2021 updated by: Baoxin Huang, Sun Yat-sen University

Esthetic, Clinical and Patient-centered Outcomes Following Immediate Implant Placement With Thin or Dehiscence Buccal Bone Wall in the Anterior Maxilla

The aim of this prospective study was to evaluate the soft and hard tissue changes of immediate implant placement with buccal bone augmentation in sites with thin labial bone wall in the anterior maxillary zone.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

The objective of this prospective controlled clinical trial is to compare the esthetic and radiographic outcomes following immediate implant placement with thin or dehiscences buccal plate using bone augmentation in combination with an absorbable collagen membrane. Subjects in need of one implant replacing tooth to be removed in the maxilla within region 13-23 are included. At least 15 patients are recruited. No implant-supported temporary restorations are used during the first 4 months. After a screw-retained provisional phase of 2 months, a final impression is taken at implant level and take-in definitive crown. Patients are recalled for oral hygiene maintenance and prosthetic controls every 6 months for the entire duration of the study.

Study Type

Interventional

Enrollment (Anticipated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Guanghua School of Stomatology,Hospital of Stomatology,Sun Yat-Sen University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

The inclusion criteria were as follows:

  1. 18 to 70-year-old;
  2. Stable periodontal and systemic health (American Society of Anesthesiologists classification I or II);
  3. Single maxillary anterior teeth (canine to canine);
  4. Bone thickness less than 1mm at 4mm apical to cementum-enamel junction (CEJ-4);
  5. Presence of adjacent nature tooth;
  6. Good compliance;
  7. No palatal vertical bone loss;
  8. Good oral hygiene.

Exclusion criteria are as follow:

  1. Uncontrolled periodontal or systemic disease;
  2. General psychiatric contraindications;
  3. More than 20 cigarettes per day;
  4. History of head and neck radiotherapy;
  5. Pregnant or expecting to be pregnant;
  6. Patients with local or generalized healing limitations;
  7. Bruxism or other destructive parafunctional habits;
  8. Drug abuse or alcohol abuse.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: thin or dehiscences buccal plate
Immediate implant placement used bone augmentation in combination with an absorbable collagen membrane with thin or dehiscences buccal plate.
Subjects in need of one implant replacing tooth to be removed in the maxilla within region 13-23 are included. At least 15 patients are recruited.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic bone volume
Time Frame: Up to 10 years after baseline
Radiographic bone volume be assessed at pre-operation, 0 ,0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Up to 10 years after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant survival
Time Frame: Up to 10 years after baseline
Implant survival will be assessed at 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Up to 10 years after baseline
Probing depth
Time Frame: Up to 10 years after baseline
Probing depth will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Up to 10 years after baseline
Modified plaque index
Time Frame: Up to 10 years after baseline
Modified plaque index will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Up to 10 years after baseline
Modified bleeding index
Time Frame: Up to 10 years after baseline
Modified bleeding index will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Up to 10 years after baseline
Buccal marginal recession
Time Frame: Up to 10 years after baseline
Buccal marginal recession will be assessed at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Up to 10 years after baseline
Papilla volume
Time Frame: Up to 10 years after baseline
Papilla volume will be assessed at 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Up to 10 years after baseline
Width of keratinized gingiva
Time Frame: Up to 10 years after baseline
Width of keratinized gingiva will be assessed at 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Up to 10 years after baseline
Oral health impact profile shortened version (OHIP-I)
Time Frame: Up to 10 years after baseline
A questionnaire will be recorded at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Up to 10 years after baseline
Change of Pink and white esthetic scores (PES/WES)
Time Frame: Change from baseline up to 10 years after implantation
Baseline will be at the time of implant placement.Pink and white esthetic scores (PES/WES) will be recorded at 0.5, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement.
Change from baseline up to 10 years after implantation
Visual analogue scale (VAS)
Time Frame: Up to 10 years after baseline
A questionnaire will be recorded at pre-operation, 0.5, 1, 1.5, 3.5, 5.5, 7.5, 10.5 years after implant placement
Up to 10 years after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Baoxin Huang, PhD, Sun Yat-sen University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2016

Primary Completion (Anticipated)

November 1, 2026

Study Completion (Anticipated)

November 1, 2027

Study Registration Dates

First Submitted

September 14, 2017

First Submitted That Met QC Criteria

October 23, 2017

First Posted (Actual)

October 24, 2017

Study Record Updates

Last Update Posted (Actual)

February 9, 2021

Last Update Submitted That Met QC Criteria

February 8, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Jaw, Edentulous, Partially

Clinical Trials on buccal bone augmentation

3
Subscribe